The following is a summary of information provided by the
New Jersey Department of Environmental Protection (
NJDEP) via email:
Kennedy Memorial Hospital University Medical Center (the licensee) was scheduled to administer a Nordion TheraSphere therapy (116 mCi of Y-90) to a patient. The target organ was the right hepatic lobe of the liver. There was a tubing failure in the delivery system and the administration was suspended. It is estimated that only 2.62 mCi (17 percent) of the prescribed dosage was administered.
The patient and referring physician were notified. The patient has been re-scheduled for treatment.
No release of licensed material or contamination was reported.
The licensee will follow-up with a full written report. The licensee is sending the equipment that failed to the manufacturer for detailed analysis.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.